Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Learning to save limbs: education program aims to cut hospital stays

NCT ID NCT07201168

Symptom relief Sponsor: Tulip Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested a 4-week educational program for 184 people with critical limb ischemia, a severe form of peripheral artery disease that can lead to amputation. The program included group sessions, digital materials, and peer support to teach patients about their condition and lifestyle changes. Researchers measured hospitalizations and quality of life over 12 months to see if the program made a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
structured multimodal educational program
What this could lead to
If successful, this program could offer a low-cost way to help patients manage their condition, reduce hospital visits, and improve daily life.
What could go wrong
This is a completed study with 184 participants, but education alone may not prevent serious complications like amputation. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

184 people

The number who actually took part.

Started

Sep 2024

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥18 years * Confirmed diagnosis of chronic critical limb ischemia (CLI) * Rutherford category 2-5 * Ability to understand study procedures and provide signed and dated written informed consent * Fluency in Russian language * Access to telephone and internet Exclusion Criteria: * Severe cognitive impairment * Participation in another clinical trial that might interfere with study outcomes * Planned major amputation within 3 months * Diabet 1 and 2 type * Inability to attend scheduled educational sessions * Severe visual or hearing impairments that would interfere with participation in educational sessions * Patients who declined to participate after being informed about the study protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic limb-threatening ischemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Limb-Threatening Ischemia Health Education limb ischemia peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic limb-threatening ischemia Health education Peripheral arterial disease

Contacts and locations

Locations

  • NCJSC "Astana Medical University"

    Astana, Kazakhstan

More trials for these conditions

Other studies related to the condition(s) this trial covers.